agilon health, inc. is classed by the SEC under Services-Misc Health & Allied Services, NEC (industry code 8090), based in Westerville, OH. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $5.9 billion and a loss of $391 million (its filed statements).
Usage businessServices-Misc Health & Allied Services, NECWesterville, OHfilings since 20208 of 9 filed, 1 estimated
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a usage business: prior from its industry code (SEC 8090, Services-Misc Health & Allied Services, NEC); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 4.2 out of ten, 8 of 9 metrics filed and 1 estimated: past 4.9 out of ten, present 4.4 out of ten, future 3.3 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 3.2 out of ten. 1 warning event since 2020; the latest 2025-11-07. 32nd percentile among 11 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 5.8 out of ten. +39.8% a year over 7 filed years; profitable in 0 of 7. 58th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 5.6 out of ten. CrossAssetData estimate 5.6/10, confidence 20 of 100 (family median). 50th percentile among 10 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
Financial health (present): 2.7 out of ten. ROE -309%: lost 309¢ per shareholder dollar. Leverage 90%: owes 90¢ per asset dollar. 27th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 6.4 out of ten. top 36% of 10 in its family; net margin -6.6%. 64th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 2.7 out of ten. bottom 27% of 7 in its family for leadership; chief executive since 2026. 27th percentile among 7 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 5.5 out of ten. top 45% of 10 in its family for room to expand. 55th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 3.5 out of ten. bottom 35% of 10 in its family for growth drivers. 35th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 1.5 out of ten. bottom 15% of 10 in its family for expectations against reality. 15th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-25 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-05 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-05 (on EDGAR). Newest filing: Form 4, 2026-08-18. Filings on record since 2020. Read from EDGAR 2026-10-12.
Where the revenue comes from
Product and service lines in fiscal 2025: Medical Services 100%, Other Operating under 1%. As tagged in its annual report (Form 10-K, filed 2026-02-25).
Who runs it
O'Rourke, Timothy Patrick (CEO & President); Schwaneke, Jeffrey A. (Chief Financial Officer); Gertsch, Timothy (Chief Accounting Officer); Zamore, Denise (Chief Legal Officer); Shaker, Benjamin (Chief Markets Officer); Venkatachaliah, Girish (Chief Technology Officer); Battaglia, Silvana (director); Mansukani, Sharad (director); Mckenzie, Diana (director); Mcloughlin, Karen (director); and 2 more. 12 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.